Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients

International Journal of Cancer

Volumn 92, Issue 1, 2001, Pages 96-105

  Feuerer, Markus ^a   Rocha, Marian ^a   Bai, Lianhua ^a   Umansky, Victor ^a   Solomayer, Erich Franz ^b   Bastert, Gunther ^b   Diel, Ingo J ^b   Schirrmacher, Volker ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Flow cytometry; HL4 tetramer; Lymphocyte activation; Tumor antigen; Tumor dormancy

Indexed keywords

CYTOKERATIN 19; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BONE MARROW; BREAST CANCER; CANCER IMMUNOLOGY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOLOGICAL MEMORY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MEMORY CELL; NATURAL KILLER CELL; ONCOGENE NEU; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR CELL;

EID: 0035314014     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(200102)9999:9999<::AID-IJC1152>3.0.CO;2-Q     Document Type: Article

References (34)

1. Detection and clinical importance of micrometastatic disease
2. Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients
3. Hunting down the seminal cell of clinical metastases
4. Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates width long-term immunological protection
5. Eb-lacZ tumor dormancy in bone marrow and lymph nodes: Active control of proliferating tumor cells by CD8+ immune T cells
6. Tumor immunology: The glass is half full
7. T and B memory cells
8. Response of naive and memory CD8+ T cells to antigen stimulation in vivo
9. Micrometastatic breast cancer cells in bone marrow at primary surgery - Prognostic value in comparison to nodal status
10. Bacterial lipopolysaccharide mediates the loss of CD4 from the surface of purified peripheral blood monocytes
11. Lymphocyte subsets in normal bone marrow
12. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood
13. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency
14. Propagation of large numbers of T cells with natural killer cell markers
15. Cytokine treatment of human bone marrow activates anti-leukaemia effector cells: Monitoring of purging by polymerase chain reaction and DNA analysis
16. Cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression
17. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages
18. Sialoadhesin-positive host macrophages play an essential role in graft versus leukemia (GvL) reactivity in mice
19. Tumor specific CTL response requiring interactions of four different cell types and dual recognition of MHC class I and class II restricted tumor antigens
20. Lifespan of human lymphocyte subsets defined by CD45 isoforms
21. Human CD8+ T lymphocytes can be divided into CD45RA+ and CD45RO+ cells with different requirements for activation and differentiation
22. Flow cytometric detection of perforin in normal human lymphocyte sub-populations defined by expression of activation/differentiation antigens
23. Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells
24. Memory B lymphocytes migrate to bone marrow in humans
25. Characterization of CD4+ T cells in mouse bone marrow. I. Increased activated/memory phenotype and altered TCR V-beta repertoire
26. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
27. HER-2/neu protein: A target for antigen specific immunotherapy of human cancer
28. Molecular portraits of human breast tumours
29. Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines
30. Tumor antigenspecific immunization of bone marrow transplantation donors as adoptive therapy against established tumor
31. Bone marrow contains virus-specific cytotoxic T lymphocvtes
32. Outcome of primary-breast-cancer patients with micrometastases: A long-term follow-up study